Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Identification and molecular epidemiology of methicillin resistant Staphylococcus pseudintermedius strains isolated from canine clinical samples in Argentina.

Gagetti P, Wattam AR, Giacoboni G, De Paulis A, Bertona E, Corso A, Rosato AE.

BMC Vet Res. 2019 Jul 27;15(1):264. doi: 10.1186/s12917-019-1990-x.

2.

VraSR and Virulence Trait Modulation during Daptomycin Resistance in Methicillin-Resistant Staphylococcus aureus Infection.

Taglialegna A, Varela MC, Rosato RR, Rosato AE.

mSphere. 2019 Feb 13;4(1). pii: e00557-18. doi: 10.1128/mSphere.00557-18.

3.

Activity of Telavancin against Staphylococcus aureus Isolates, Including Those with Decreased Susceptibility to Ceftaroline, from Cystic Fibrosis Patients.

Roch M, Varela MC, Taglialegna A, Rose WE, Rosato AE.

Antimicrob Agents Chemother. 2018 Aug 27;62(9). pii: e00956-18. doi: 10.1128/AAC.00956-18. Print 2018 Sep.

4.

Daptomycin Resistance in Clinical MRSA Strains Is Associated with a High Biological Fitness Cost.

Roch M, Gagetti P, Davis J, Ceriana P, Errecalde L, Corso A, Rosato AE.

Front Microbiol. 2017 Dec 5;8:2303. doi: 10.3389/fmicb.2017.02303. eCollection 2017.

5.

Combination Antibiotic Exposure Selectively Alters the Development of Vancomycin Intermediate Resistance in Staphylococcus aureus.

Zheng X, Berti AD, McCrone S, Roch M, Rosato AE, Rose WE, Chen B.

Antimicrob Agents Chemother. 2018 Jan 25;62(2). pii: e02100-17. doi: 10.1128/AAC.02100-17. Print 2018 Feb.

6.

Molecular Bases Determining Daptomycin Resistance-Mediated Resensitization to β-Lactams (Seesaw Effect) in Methicillin-Resistant Staphylococcus aureus.

Renzoni A, Kelley WL, Rosato RR, Martinez MP, Roch M, Fatouraei M, Haeusser DP, Margolin W, Fenn S, Turner RD, Foster SJ, Rosato AE.

Antimicrob Agents Chemother. 2016 Dec 27;61(1). pii: e01634-16. doi: 10.1128/AAC.01634-16. Print 2017 Jan.

7.

Modeling Meropenem Treatment, Alone and in Combination with Daptomycin, for KPC-Producing Klebsiella pneumoniae Strains with Unusually Low Carbapenem MICs.

Gagetti P, Pasteran F, Martinez MP, Fatouraei M, Gu J, Fernandez R, Paz L, Rose WE, Corso A, Rosato AE.

Antimicrob Agents Chemother. 2016 Jul 22;60(8):5047-50. doi: 10.1128/AAC.00168-16. Print 2016 Aug.

8.

The Staphylococcus aureus Chaperone PrsA Is a New Auxiliary Factor of Oxacillin Resistance Affecting Penicillin-Binding Protein 2A.

Jousselin A, Manzano C, Biette A, Reed P, Pinho MG, Rosato AE, Kelley WL, Renzoni A.

Antimicrob Agents Chemother. 2015 Dec 28;60(3):1656-66. doi: 10.1128/AAC.02333-15.

9.

Impact of efflux in the development of multidrug resistance phenotypes in Staphylococcus aureus.

Santos Costa S, Viveiros M, Rosato AE, Melo-Cristino J, Couto I.

BMC Microbiol. 2015 Oct 24;15:232. doi: 10.1186/s12866-015-0572-8.

10.

PBP2a mutations causing high-level Ceftaroline resistance in clinical methicillin-resistant Staphylococcus aureus isolates.

Long SW, Olsen RJ, Mehta SC, Palzkill T, Cernoch PL, Perez KK, Musick WL, Rosato AE, Musser JM.

Antimicrob Agents Chemother. 2014 Nov;58(11):6668-74. doi: 10.1128/AAC.03622-14. Epub 2014 Aug 25.

11.

Ceftaroline is active against heteroresistant methicillin-resistant Staphylococcus aureus clinical strains despite associated mutational mechanisms and intermediate levels of resistance.

Fernandez R, Paz LI, Rosato RR, Rosato AE.

Antimicrob Agents Chemother. 2014 Oct;58(10):5736-46. doi: 10.1128/AAC.03019-14. Epub 2014 Jul 14.

12.

TCA cycle-mediated generation of ROS is a key mediator for HeR-MRSA survival under β-lactam antibiotic exposure.

Rosato RR, Fernandez R, Paz LI, Singh CR, Rosato AE.

PLoS One. 2014 Jun 16;9(6):e99605. doi: 10.1371/journal.pone.0099605. eCollection 2014.

13.

Staphylococcal phenotypes induced by naturally occurring and synthetic membrane-interactive polyphenolic β-lactam resistance modifiers.

Palacios L, Rosado H, Micol V, Rosato AE, Bernal P, Arroyo R, Grounds H, Anderson JC, Stabler RA, Taylor PW.

PLoS One. 2014 Apr 3;9(4):e93830. doi: 10.1371/journal.pone.0093830. eCollection 2014.

14.

Identification of point mutations in clinical Staphylococcus aureus strains that produce small-colony variants auxotrophic for menadione.

Dean MA, Olsen RJ, Long SW, Rosato AE, Musser JM.

Infect Immun. 2014 Apr;82(4):1600-5. doi: 10.1128/IAI.01487-13. Epub 2014 Jan 22.

15.

Exposure of clinical MRSA heterogeneous strains to β-lactams redirects metabolism to optimize energy production through the TCA cycle.

Keaton MA, Rosato RR, Plata KB, Singh CR, Rosato AE.

PLoS One. 2013 Aug 5;8(8):e71025. doi: 10.1371/journal.pone.0071025. Print 2013.

16.

Targeting of PBP1 by β-lactams determines recA/SOS response activation in heterogeneous MRSA clinical strains.

Plata KB, Riosa S, Singh CR, Rosato RR, Rosato AE.

PLoS One. 2013 Apr 23;8(4):e61083. doi: 10.1371/journal.pone.0061083. Print 2013.

17.

β-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivatives.

Mehta S, Singh C, Plata KB, Chanda PK, Paul A, Riosa S, Rosato RR, Rosato AE.

Antimicrob Agents Chemother. 2012 Dec;56(12):6192-200. doi: 10.1128/AAC.01525-12. Epub 2012 Sep 17.

18.

Thiadiazolidinones: a new class of alanine racemase inhibitors with antimicrobial activity against methicillin-resistant Staphylococcus aureus.

Ciustea M, Mootien S, Rosato AE, Perez O, Cirillo P, Yeung KR, Ledizet M, Cynamon MH, Aristoff PA, Koski RA, Kaplan PA, Anthony KG.

Biochem Pharmacol. 2012 Feb 1;83(3):368-77. doi: 10.1016/j.bcp.2011.11.021. Epub 2011 Nov 29.

19.

VraSR two-component regulatory system contributes to mprF-mediated decreased susceptibility to daptomycin in in vivo-selected clinical strains of methicillin-resistant Staphylococcus aureus.

Mehta S, Cuirolo AX, Plata KB, Riosa S, Silverman JA, Rubio A, Rosato RR, Rosato AE.

Antimicrob Agents Chemother. 2012 Jan;56(1):92-102. doi: 10.1128/AAC.00432-10. Epub 2011 Oct 10.

20.

Fate of mutation rate depends on agr locus expression during oxacillin-mediated heterogeneous-homogeneous selection in methicillin-resistant Staphylococcus aureus clinical strains.

Plata KB, Rosato RR, Rosato AE.

Antimicrob Agents Chemother. 2011 Jul;55(7):3176-86. doi: 10.1128/AAC.01119-09. Epub 2011 May 2.

21.

Trial of universal gloving with emollient-impregnated gloves to promote skin health and prevent the transmission of multidrug-resistant organisms in a surgical intensive care unit.

Bearman G, Rosato AE, Duane TM, Elam K, Sanogo K, Haner C, Kazlova V, Edmond MB.

Infect Control Hosp Epidemiol. 2010 May;31(5):491-7. doi: 10.1086/651671.

PMID:
20350197
22.

Nasal carriage of inducible dormant and community-associated methicillin-resistant Staphylococcus aureus in an ambulatory population of predominantly university students.

Bearman GM, Rosato AE, Assanasen S, Kleiner EA, Elam K, Haner C, Wenzel RP.

Int J Infect Dis. 2010 Sep;14 Suppl 3:e18-24. doi: 10.1016/j.ijid.2009.09.005. Epub 2010 Jan 29.

23.

Staphylococcus aureus as an infectious agent: overview of biochemistry and molecular genetics of its pathogenicity.

Plata K, Rosato AE, Wegrzyn G.

Acta Biochim Pol. 2009;56(4):597-612. Epub 2009 Dec 11. Review.

24.

Differential expression of ccrA in methicillin-resistant Staphylococcus aureus strains carrying staphylococcal cassette chromosome mec type II and IVa elements.

Higgins PG, Rosato AE, Seifert H, Archer GL, Wisplinghoff H.

Antimicrob Agents Chemother. 2009 Oct;53(10):4556-8. doi: 10.1128/AAC.00395-09. Epub 2009 Jul 13.

25.
26.

Unusual form of oxacillin resistance in methicillin-resistant Staphylococcus aureus clinical strains.

Forbes BA, Bombicino K, Plata K, Cuirolo A, Webber D, Bender CL, Rosato AE.

Diagn Microbiol Infect Dis. 2008 Aug;61(4):387-95. doi: 10.1016/j.diagmicrobio.2008.04.003. Epub 2008 May 27.

PMID:
18508224
27.

Identification and phenotypic characterization of a beta-lactam-dependent, methicillin-resistant Staphylococcus aureus strain.

Goldstein F, Perutka J, Cuirolo A, Plata K, Faccone D, Morris J, Sournia A, Kitzis MD, Ly A, Archer G, Rosato AE.

Antimicrob Agents Chemother. 2007 Jul;51(7):2514-22. Epub 2007 Apr 30.

28.

Susceptibility of coagulase-negative staphylococcal nosocomial bloodstream isolates to the chlorhexidine/silver sulfadiazine-impregnated central venous catheter.

Rosato AE, Tallent SM, Edmond MB, Bearman GM.

Am J Infect Control. 2004 Dec;32(8):486-8. No abstract available.

PMID:
15573055
29.

Related clones containing SCCmec type IV predominate among clinically significant Staphylococcus epidermidis isolates.

Wisplinghoff H, Rosato AE, Enright MC, Noto M, Craig W, Archer GL.

Antimicrob Agents Chemother. 2003 Nov;47(11):3574-9.

30.
31.

mecA-blaZ corepressors in clinical Staphylococcus aureus isolates.

Rosato AE, Kreiswirth BN, Craig WA, Eisner W, Climo MW, Archer GL.

Antimicrob Agents Chemother. 2003 Apr;47(4):1460-3.

32.

Conversion of oxacillin-resistant staphylococci from heterotypic to homotypic resistance expression.

Finan JE, Rosato AE, Dickinson TM, Ko D, Archer GL.

Antimicrob Agents Chemother. 2002 Jan;46(1):24-30.

33.

Inducible macrolide resistance in Corynebacterium jeikeium.

Rosato AE, Lee BS, Nash KA.

Antimicrob Agents Chemother. 2001 Jul;45(7):1982-9.

Supplemental Content

Loading ...
Support Center